LENZ
LENZ Therapeutics
LENZ
LENZ
113 hedge funds and large institutions have $725M invested in LENZ Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
11.34% more ownership
Funds ownership: 76.52% → 87.85% (+11%)
8% more funds holding
Funds holding: 105 → 113 (+8)
Holders
113
Holding in Top 10
5
Calls
$11.5M
Puts
$305K
Top Buyers
| 1 | +$15.9M | |
| 2 | +$10.8M | |
| 3 | +$9.34M | |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
+$9.31M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$7.25M |
Top Sellers
| 1 | -$7.94M | |
| 2 | -$6.37M | |
| 3 | -$4.99M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$1.09M |
| 5 |
BP
BBR Partners
New York
|
-$1.03M |